Evidence map›Paper›PMID 33309989›Full record

ReviewBone2021

MicroRNA function in craniofacial bone formation, regeneration and repair.

Liu Hong, Hongli Sun, Brad A Amendt

Open access · greenAbstract readReview
In one paragraph

Review in Bone, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. International journal of molecular sciences · 2025
    Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Exploring microRNAs in craniofacial regenerative medicine.Biochemical Society transactions · 2023
    Review
  15. Article
  16. Article
  17. Plasmid encodingNanomedicine (London, England) · 2022
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Liu HongIowa Institute for Oral Health Research, The University of Iowa, Iowa City, IA, USA.
Hongli SunIowa Institute for Oral Health Research, The University of Iowa, Iowa City, IA, USA.
Brad A AmendtIowa Institute for Oral Health Research, The University of Iowa, Iowa City, IA, USA; The University of Iowa, Department of Anatomy and Cell Biology, Iowa City, IA, USA; Craniofacial Anomalies Research Center, The University of Iowa, Iowa City, IA, USA. Electronic address: brad-amendt@uiowa.edu.
University of Iowa · US

Funding

University of Iowa Institutional Training Program in Oral Health ResearchT90DE023520 · NIDCR · UNIVERSITY OF IOWA · PI STEVEN M. LEVY · 2013 to 2026
$5.6M
Molecular Mechanisms of PITX2 During Craniofacial DevelopmentR01DE013941 · NIDCR · UNIVERSITY OF TULSA · PI AMENDT, BRAD A · 2000 to 2013
$4.2M
Co-opting Lef-1 and miR-26b activities to regulate dental stem cells and their progenyR01DE028527 · NIDCR · UNIVERSITY OF IOWA · PI AMENDT, BRAD A, CAO, HUOJUN · 2020 to 2024
$2.1M
Oral and Craniofacial Bone Regeneration using MicroRNA ModulationR01DE026433 · NIDCR · UNIVERSITY OF IOWA · PI AMENDT, BRAD A, HONG, LIU · 2017 to 2021
$1.8M
Rejuvenating aged bone regeneration by innovative nanomaterials-mediated drug deliveryR01DE029159 · NIDCR · UNIVERSITY OF IOWA · PI SUN, HONGLI · 2020 to 2024
$1.8M
New Biotechnology using MicroRNA Inhibitors to Regenerate Alveolar BoneR43DE027569 · NIDCR · NATUREMIRI, LLC · PI SANDRA, ALEXANDER · 2018 to 2018
$225k
Hybrid 3D bioprinting of bone using microRNA-based bioinkR03EB025873 · NIBIB · UNIVERSITY OF IOWA · PI AMENDT, BRAD A · 2018 to 2019
$153k
NIBIB NIH HHS R03 EB025873NIDCR NIH HHS R01 DE013941NIDCR NIH HHS R01 DE026433NIDCR NIH HHS R01 DE028527NIDCR NIH HHS R01 DE029159NIDCR NIH HHS R43 DE027569NIDCR NIH HHS T90 DE023520
6 · The paper itself

Abstract

Bone formation in the craniofacial complex is regulated by cranial neural crest (CNC) and mesoderm-derived cells. Different elements of the developing skull, face, mandible, maxilla (jaws) and nasal bones are regulated by an array of transcription factors, signaling molecules and microRNAs (miRs). miRs are molecular modulators of these factors and act to restrict their expression in a temporal-spatial mechanism. miRs control the different genetic pathways that form the craniofacial complex. By understanding how miRs function in vivo during development they can be adapted to regenerate and repair craniofacial genetic anomalies as well as bone diseases and defects due to traumatic injuries. This review will highlight some of the new miR technologies and functions that form new bone or inhibit bone regeneration.

Indexed as

Bone RegenerationMicroRNAsOsteogenesisAnimalsHumansMaxillaNeural CrestSkullMicroRNAsBone developmentBone regenerationBone repairmicroRNA inhibitor system (PMIS)microRNA mouse modelsmicroRNA therapeutic

Identifiers

PMID33309989
PMCPMC7869528
OpenAlexW3113011624

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.